Company Information
USD
25.36
- (-3.3%)
NASDAQ:GH, GUARDANT HEALTH, INC.
Industry: Diagnostics & Research
End of Day: 17 May 2024 GMT-4
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Address
3100 Hanover Street
Classification
Sector
Healthcare
Industry Group
Medical Diagnostics & Research
Industry
Diagnostics & Research
Key Executives
Mr. Ian T. Clark
Director
Ms. Myrtle S. Potter
Director
Ms. Vijaya Gadde
Director
Mr. Steve E. Krognes
Director
Mr. Michael Brian Bell
CFO/Chief Accounting Officer
Mr. Helmy Eltoukhy
Chairman of the Board/Co-CEO/Co-Founder/Director
Dr. AmirAli Talasaz
Co-CEO/Co-Founder/Director
Ms. Meghan V. Joyce
Director
Mr. Musa Tariq
Director
Ms. Darya Chudova
Chief Technology Officer
Dr. Craig Eagle, M.D.
Chief Medical Officer
Mr. John G. Saia
Chief Legal Officer/Secretary
Mr. Kumud Kalia
Chief Information Officer
Ms. Amelia Merrill
Senior VP, Divisional
Mr. Christopher Freeman
Other Executive Officer
Ownership
Institution Holdings
Vanguard Group Inc
11,130,654 (9.145%)
BlackRock Inc
10,831,716 (8.899%)
FMR LLC
8,933,365 (7.360%)
CAPITAL INTERNATIONAL INVESTORS
7,879,355 (6.491%)
Capital Research and Management Company
6,317,543 (5.191%)
Baillie Gifford & Co Limited.
6,178,812 (5.077%)
Fidelity Management & Research Company LLC
6,053,900 (4.974%)
FMR Inc
5,251,349 (4.315%)
Deep Track Capital, LP
5,000,000 (4.108%)
Morgan Stanley
4,953,699 (4.081%)
Funds Holdings
Vanguard Total Stock Market Index Fund
3,524,219 (2.896%)
Vanguard US Total Market Shares ETF
3,524,219 (2.896%)
Vanguard Small Cap Index
2,862,490 (2.352%)
iShares Russell 2000 ETF
2,760,634 (2.268%)
Eventide Gilead Fund
2,717,741 (2.233%)
Vanguard Institutional Extnd Mkt Idx Tr
1,744,814 (1.434%)
American Funds IS® Growth Fund
1,618,159 (1.329%)
Capital Group Growth Composite
1,618,159 (1.329%)
Vanguard Small Cap Growth Index Fund
1,594,692 (1.310%)
Baillie Gifford American Fund
1,487,221 (1.222%)
Make Smart Investment Choices